Disclosure of Executive Health Information: Balancing Investor Rights and Executive Privacy

1796 Words4 Pages

Though the Securities and Exchange Commission rules governing selective disclosure and insider trading contain no provisions relating specifically to the health of executives, publicly traded companies must nonetheless manage the potential implications of their key executives’ health on perceptions of the company’s future success as well as their propriety in disclosing information material to investors. This can be a difficult task, as an employer disclosing particulars about an employee’s health seems to run contrary to the special privacy protections given health information in the U.S., yet such information can undeniably affect investors’ decisions. Recently, the Securities and Exchange Commission launched a probe to evaluate statements made by Apple, Inc. regarding the health of CEO Steve Jobs. While not yet a formal investigation, this unprecedented evaluation of health-related disclosures raises significant issues about how such information should be treated and how the rights of investors are to be weighed against the rights of executives. Additionally, if this practice becomes regular, it could lead to unfair and burdensome erosions of executives’ rights to privacy and medical autonomy.

Background

In 2003, Jobs was diagnosed with a rare form of pancreatic cancer that, unlike most forms of the disease, could be treated reliably and successfully with a surgical procedure. Against the recommendations of his doctors, Jobs initially tried to address his illness by adopting a special diet regimen. However, nine months after his diagnosis, he was forced to accept the prescribed treatment when a scan revealed that the tumor in his pancreas had grown. Apple broke the news about Jobs’ illness and surgery on the heels of the ...

... middle of paper ...

...sion=2008030510.

Gullo, K., C. Guglielmo, and D. Scheer (2009). SEC review of Apple may pit investors against privacy (Update 2). Accessed on February 15, 2009 at: http://www.bloomberg. com/apps/news?pid=20601109&sid=a3N36w1tFNbc&refer=home.

Hargreaves, S. (2008). Apple’s stock hit by Web rumor. Accessed on February 15, 2009 at: http://money.cnn.com/2008/10/03/technology/apple/index.htm.

Kane, Y. I. and K. Scannell (2009). Apple bests downturn, but faces SEC probe. Accessed on February 15, 2009 at: http://online.wsj.com/article/SB123255729957302873.html.

Tobak, S. (2009). Did Apple break SEC disclosure rules re: Steve Jobs’ health? Accessed on February 15, 2009 at: http://blogs.bnet.com/ceo/?p=1660.

U.S. Securities and Exchange Comission (2000). Selective disclosure and insider trading. Accessed on February 15, 2009 at: http://www.sec.gov/rules/final/33-7881.htm.

More about Disclosure of Executive Health Information: Balancing Investor Rights and Executive Privacy

Open Document